Corpay vs RB Global
CPAY and RBA side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CPAY and RBA compare
Corpay is the larger company, worth 1.6 times as much as RB Global ($26.3B against $16.6B).
On earnings, Corpay is cheaper: it trades at 24.4× trailing earnings, against 38.5× for RB Global.
Corpay grew revenue faster over the last twelve months (20.4% versus 9.7% for RB Global).
Corpay keeps more of each dollar of sales as profit, with a net margin of 22.7% compared with 10.0% at RB Global.
RB Global pays a dividend yielding 0.71%; Corpay does not pay one.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CPAY | RBA |
|---|---|---|
| Size and price | ||
| Market cap | $26.3B | $16.6B |
| Share price | $400.94 | $89.69 |
| Change, 1 year | 49.5% | −10.2% |
| Change, 5 years | 63.8% | 20.4% |
| Beta (5Y) | 1.17 | 0.53 |
| Employees | 12K | 8,000 |
| StockData Score | ||
| Total score | 11 | 11 |
| Valuation score | 2 | 2 |
| Growth score | 2 | 2 |
| Performance score | 5 (better) | 3 |
| Health score | 2 | 3 (better) |
| Dividend score | 0 | 1 (better) |
| Valuation | ||
| P/E | 24.4× (better) | 38.5× |
| P/S | 5.2× | 3.4× (better) |
| P/B | 7.4× | 3.0× (better) |
| EV/EBITDA | 10.5× (better) | 14.8× |
| P/FCF | 16.1× (better) | 27.2× |
| PEG | 3.71 | – |
| FCF yield | 6.2% (better) | 3.7% |
| Fair value | $405.01 | $87.30 |
| Margin of safety | 1.0% (better) | −2.7% |
| Growth | ||
| Revenue growth (TTM) | 20.4% (better) | 9.7% |
| Revenue growth, 5Y average | 13.6% | 27.2% (better) |
| Net income growth (TTM) | 8.7% | 15.9% (better) |
| EPS growth (TTM) | 11.8% | 15.3% (better) |
| EPS growth, 5Y average | 13.1% (better) | 5.8% |
| Profitability | ||
| Operating margin | 43.7% (better) | 16.0% |
| Net margin | 22.7% (better) | 10.0% |
| FCF margin | 32.6% (better) | 12.6% |
| Return on equity | 30.5% (better) | 8.8% |
| Return on invested capital | 34.0% (better) | 8.2% |
| Financial health | ||
| Debt / equity | 1.28 | 0.52 (better) |
| Net debt / EBITDA | 0.52 (better) | 1.85 |
| Interest coverage | 5.0× (better) | 4.3× |
| Current ratio | 0.97 | 1.31 (better) |
| Altman Z-score | 1.59 | 2.34 (better) |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 0.71% |
| Buyback yield | 6.5% | – |
| Shareholder yield | 6.5% (better) | 0.71% |
| Ownership | ||
| Held by institutions | 97.8% | 98.3% |
| Held by insiders | 5.3% | 0.21% |
| Insider net buying, 12 months | −$146M | −$2.1M (better) |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 5.6% | 8.9% |
Go deeper
- CPAY stock overview
- CPAY income statement
- CPAY valuation and score
- RBA stock overview
- RBA income statement
- RBA valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.